PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing

Private placement yields $2.5 million from the sale of Veris Health common stock at a $35 million pre-money valuation.

NEW YORK, June 24, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiary, Veris Health Inc. ("Veris"), today announced the completion of a private placement equity financing directly into Veris, yielding $2.5 million in proceeds (gross and net). This supplements a prior $2.4 million financing completed earlier this year.

Read more at prnewswire.com